CN105669809A - 一种醋酸可的松的制备方法 - Google Patents
一种醋酸可的松的制备方法 Download PDFInfo
- Publication number
- CN105669809A CN105669809A CN201610149209.3A CN201610149209A CN105669809A CN 105669809 A CN105669809 A CN 105669809A CN 201610149209 A CN201610149209 A CN 201610149209A CN 105669809 A CN105669809 A CN 105669809A
- Authority
- CN
- China
- Prior art keywords
- reaction
- preparation
- bromine
- iodine
- iodine liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 title claims abstract description 17
- 229960003290 cortisone acetate Drugs 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 28
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 23
- 239000011630 iodine Substances 0.000 claims abstract description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 125000002346 iodo group Chemical group I* 0.000 claims abstract description 13
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 12
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 12
- 239000000376 reactant Substances 0.000 claims abstract description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 3
- 239000013067 intermediate product Substances 0.000 claims abstract description 3
- KURZCZMGELAPSV-UHFFFAOYSA-N [Br].[I] Chemical compound [Br].[I] KURZCZMGELAPSV-UHFFFAOYSA-N 0.000 claims description 17
- 238000005649 metathesis reaction Methods 0.000 claims description 13
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 11
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 6
- 239000001110 calcium chloride Substances 0.000 claims description 6
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 5
- 239000011592 zinc chloride Substances 0.000 claims description 5
- 235000005074 zinc chloride Nutrition 0.000 claims description 5
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical group [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000292 calcium oxide Substances 0.000 claims description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- 229910001507 metal halide Inorganic materials 0.000 claims description 3
- 150000005309 metal halides Chemical group 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910044991 metal oxide Inorganic materials 0.000 claims description 2
- 150000004706 metal oxides Chemical group 0.000 claims description 2
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 239000012467 final product Substances 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- SIJWOBYTUKWIJT-UHFFFAOYSA-M [Cl-].[Ca+2].[O-2].[Ca+2] Chemical compound [Cl-].[Ca+2].[O-2].[Ca+2] SIJWOBYTUKWIJT-UHFFFAOYSA-M 0.000 description 2
- OTCQGVUVGDMSEZ-UHFFFAOYSA-M calcium zinc oxygen(2-) chloride Chemical compound [Cl-].[Ca+2].[O-2].[Zn+2] OTCQGVUVGDMSEZ-UHFFFAOYSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PUUODCSAWVPUJD-UHFFFAOYSA-M [O-2].[Zn+2].[Cl-].[Zn+2] Chemical compound [O-2].[Zn+2].[Cl-].[Zn+2] PUUODCSAWVPUJD-UHFFFAOYSA-M 0.000 description 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000004896 high resolution mass spectrometry Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
碘用量/g | 助溶剂 | 催化剂 | 收率/% | |
实施例1 | 57.5 | 氯化钙 | 氧化钙 | 102.0%-103.5% |
实施例2 | 57.5 | 氯化锌 | 氧化锌 | 99.7%-100.2% |
实施例3 | 57.5 | 氯化锌 | 氧化钙 | 101.5%-102.1% |
实施例4 | 57.5 | 氯化钙 | 氧化锌 | 100.8%-101.3% |
对照实施例1 | 108 | 氯化钙 | 氧化钙 | 99.0%-99.8% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610149209.3A CN105669809B (zh) | 2016-03-16 | 2016-03-16 | 一种醋酸可的松的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610149209.3A CN105669809B (zh) | 2016-03-16 | 2016-03-16 | 一种醋酸可的松的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105669809A true CN105669809A (zh) | 2016-06-15 |
CN105669809B CN105669809B (zh) | 2017-04-12 |
Family
ID=56215213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610149209.3A Active CN105669809B (zh) | 2016-03-16 | 2016-03-16 | 一种醋酸可的松的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105669809B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106866765A (zh) * | 2016-12-12 | 2017-06-20 | 河南利华制药有限公司 | 一种醋酸可的松的制备方法 |
CN114075259A (zh) * | 2020-08-14 | 2022-02-22 | 保定九孚生化有限公司 | 一种醋酸可的松母液的回收方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101838301A (zh) * | 2009-10-16 | 2010-09-22 | 吴美洲 | 含氟甾体化合物的制备方法 |
CN102617686A (zh) * | 2012-03-16 | 2012-08-01 | 浙江凯迪药业有限公司 | 一种泼尼松的制备方法 |
CN102964413A (zh) * | 2012-11-29 | 2013-03-13 | 浙江仙琚制药股份有限公司 | 化合物可的松醋酸酯的制备方法 |
CN103923145A (zh) * | 2014-04-16 | 2014-07-16 | 江苏远大仙乐药业有限公司 | 一种醋酸可的松重要中间体的制备方法 |
-
2016
- 2016-03-16 CN CN201610149209.3A patent/CN105669809B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101838301A (zh) * | 2009-10-16 | 2010-09-22 | 吴美洲 | 含氟甾体化合物的制备方法 |
CN102617686A (zh) * | 2012-03-16 | 2012-08-01 | 浙江凯迪药业有限公司 | 一种泼尼松的制备方法 |
CN102964413A (zh) * | 2012-11-29 | 2013-03-13 | 浙江仙琚制药股份有限公司 | 化合物可的松醋酸酯的制备方法 |
CN103923145A (zh) * | 2014-04-16 | 2014-07-16 | 江苏远大仙乐药业有限公司 | 一种醋酸可的松重要中间体的制备方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106866765A (zh) * | 2016-12-12 | 2017-06-20 | 河南利华制药有限公司 | 一种醋酸可的松的制备方法 |
CN114075259A (zh) * | 2020-08-14 | 2022-02-22 | 保定九孚生化有限公司 | 一种醋酸可的松母液的回收方法 |
CN114075259B (zh) * | 2020-08-14 | 2024-04-12 | 保定九孚生化有限公司 | 一种醋酸可的松母液的回收方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105669809B (zh) | 2017-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103641878B (zh) | 倍他米松中间体或其类似物的制备方法 | |
CN105669811A (zh) | 新的7-酮-6β-烷基胆烷酸衍生物在制备奥贝胆酸以及其在医药领域的用途 | |
CN105669809A (zh) | 一种醋酸可的松的制备方法 | |
CN105566426A (zh) | 一种16a-羟基泼尼松龙的合成方法 | |
CN105399791A (zh) | 一种倍他米松中间体的制备方法 | |
CN109265570A (zh) | 一种高效制备淀粉纳米晶的方法 | |
CN103232369B (zh) | 一种芴甲氧羰酰谷氨酸-5-叔丁酯的制备方法 | |
CN103232370A (zh) | 一种芴甲氧羰酰天冬氨酸-4-叔丁酯的制备方法 | |
CN106397519A (zh) | 一种烯丙孕素的制备方法 | |
CN106893753A (zh) | 一种通过生物发酵一步制备泼尼松龙的方法 | |
CN104561217B (zh) | 6a‑甲基泼尼松龙的合成方法 | |
CN105294797A (zh) | 一种甲睾酮的制备方法 | |
CN103665078B (zh) | 一种17α-羟基甾体酯的制备方法 | |
CN105399790B (zh) | 一种3‑酮‑4‑雄烯‑17β羧酸的合成方法 | |
CN106893752A (zh) | 一种孕甾-1,4双键-11酮-21-醋酸酯类化合物的制备方法 | |
CN115073546A (zh) | 一种新型雄激素受体抑制剂的制备方法 | |
CN108084238A (zh) | 一种坎利酮中间体的制备方法 | |
CN103539733B (zh) | 一种对氨基水杨酸异烟肼的制备方法 | |
CN104109185A (zh) | 一种醋酸阿比特龙的制备方法 | |
CN105273029A (zh) | 一种丙酸睾酮中间体17β-羟基雄甾-4-烯-3-酮的制备方法 | |
CN105001049A (zh) | 松香酸衍生物的制备方法 | |
CN110092734A (zh) | 一种2-(苯基亚甲基)丙二腈或其衍生物的串联合成方法 | |
CN104262439B (zh) | 一种以4-雄烯二酮一步法合成睾酮的方法 | |
CN112048535B (zh) | 一种甾体中间体的制备方法 | |
CN103896951A (zh) | 2-甲基-吡唑并[1,5-a]嘧啶-6-羧酸的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Chao Inventor after: Yu Wei Inventor after: Wang Haocun Inventor before: Li Chao Inventor before: Yu Wei |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of cortisone acetate Effective date of registration: 20190220 Granted publication date: 20170412 Pledgee: Baoding Branch of Beijing Bank Co., Ltd. Pledgor: BAODING JIUFU BIOCHEMICAL CO., LTD. Registration number: 2019990000140 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210527 Granted publication date: 20170412 Pledgee: Baoding Branch of Beijing Bank Co.,Ltd. Pledgor: BAODING JIUFU BIOCHEMICAL Co.,Ltd. Registration number: 2019990000140 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 072154 Pang village, Yujiazhuang Township, Mancheng County, Baoding City, Hebei Province Patentee after: Hebei Yuanda Jiufu Biotechnology Co.,Ltd. Address before: 072154 Pang village, Yujiazhuang Township, Mancheng County, Baoding City, Hebei Province Patentee before: BAODING JIUFU BIOCHEMICAL Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |